These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31530856)

  • 1. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
    Tong Z; Guo J; Glen RC; Morrell NW; Li W
    Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
    David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
    Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
    Salmon RM; Guo J; Wood JH; Tong Z; Beech JS; Lawera A; Yu M; Grainger DJ; Reckless J; Morrell NW; Li W
    Nat Commun; 2020 Apr; 11(1):1621. PubMed ID: 32238803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
    Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
    J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
    Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
    J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
    Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
    J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated circulating BMP9 aggravates pulmonary angiogenesis in hepatopulmonary syndrome rats through ALK1-Endoglin-Smad1/5/9 signalling.
    Yang C; Sun M; Yang Y; Han Y; Wu X; Wu X; Cao H; Chen L; Lei Y; Hu X; Chen Y; Zeng Z; Li J; Shu X; Yang Z; Lu K; Li Y; Wang X; Yi B
    Eur J Clin Invest; 2024 Aug; 54(8):e14212. PubMed ID: 38591651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.
    Upton PD; Long L; Trembath RC; Morrell NW
    Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MxA Is a Novel Regulator of Endosome-Associated Transcriptional Signaling by Bone Morphogenetic Proteins 4 and 9 (BMP4 and BMP9).
    Yuan H; Sehgal PB
    PLoS One; 2016; 11(11):e0166382. PubMed ID: 27875556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway.
    Li Y; Shang Q; Li P; Yang Z; Yang J; Shi J; Ge S; Wang Y; Fan X; Jia R
    J Mol Cell Cardiol; 2020 Oct; 147():92-107. PubMed ID: 32730768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.
    Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC
    J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the ALK1 ligands, BMP9 and BMP10.
    Li W; Salmon RM; Jiang H; Morrell NW
    Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.
    Herrera B; van Dinther M; Ten Dijke P; Inman GJ
    Cancer Res; 2009 Dec; 69(24):9254-62. PubMed ID: 19996292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains.
    Kienast Y; Jucknischke U; Scheiblich S; Thier M; de Wouters M; Haas A; Lehmann C; Brand V; Bernicke D; Honold K; Lorenz S
    J Biol Chem; 2016 Feb; 291(7):3395-410. PubMed ID: 26677222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
    Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
    J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
    Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
    Olsen OE; Sankar M; Elsaadi S; Hella H; Buene G; Darvekar SR; Misund K; Katagiri T; Knaus P; Holien T
    J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29739878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.
    Rostama B; Turner JE; Seavey GT; Norton CR; Gridley T; Vary CP; Liaw L
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2626-37. PubMed ID: 26471266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.